The table below shows ALX ONCOLOGY HOLDINGS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$13.61M
$17.44M
$18.02M
$23.89M
$26.47M
$34.65M
SG&A
ALXO annual revenue (10-K history)
ALX ONCOLOGY HOLDINGS INC reported annual revenue of $0.00 for fiscal year 2022. Over the 5 fiscal years shown, annual revenue declined from $2.07M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.